Sagility Ltd Q1 FY26 Earnings Analysis

- Expect low- to mid-teens organic revenue growth in constant currency for FY '26 and beyond. - With the BroadPath acquisition fully annualized, total constant currency growth likely to exceed 20% in FY '26. - Growth driven by deepening wallet share with existing large clients and expanding into mid-market health plan clients. - Continued focus on capability-focused acquisitions for targeted growth, though inorganic revenue not included in guidance. - Non-top three clients growing even faster (15-20%+), contributing to diversified growth. - Strong deal pipeline with multiple new clients and active conversations, indicating sustained growth momentum. - No anticipated macroeconomic headwinds impacting growth expectations over the next 12 months.

- Sagility expects low- to mid-teens organic revenue growth on a constant currency basis for FY '26 and beyond. - Including the BroadPath acquisition, total constant currency growth is likely to exceed 20% for FY '26. - Adjusted EBITDA margin guidance is maintained at 24% to 25% for at least the next 12 months, with some dilution (~120-150 bps) expected due to BroadPath. - The company aims for steady-state margins around 24-25%, continuing to invest in technology and client-facing teams. - Earnings Per Share (EPS) for FY '25 grew significantly: reported EPS increased by 119.3%, and adjusted EPS grew 27.7% year-over-year. - Strong operating cash flows (~90% of EBITDA) and healthy balance sheet support sustained profit growth. - No debt-funded repayments planned; all debt repayments will be made from operational cash flow, supporting financial stability.

- The company continues to invest in technology, especially focusing on AI and GenAI, piloting several use cases with existing clients and exploring healthcare-specific solutions such as utilization management and provider data management. - Technology investments are emphasized as critical for margin resilience and operational efficiency. - Strategic investments also include M&A activity, with ongoing pursuit of acquisitions that add technology or services capabilities catering to payers and providers. - Integration of the BroadPath acquisition is a key priority before pursuing other deals. - There are no mentions of inorganic revenue being included in guidance; organic growth remains the focus. - No explicit mention of traditional capex spend; focus is rather on technology capability building and strategic acquisitions funded through operational cash flow.

- The company plans to repay existing debt using operationally generated cash and will not borrow to repay debts. - There is no intention for promoter-level selling or offer for sale (OFS) to repay debt. - No equity funding is planned in the short term to fund debt repayment. - Debt repayments are structured with no prepayment option currently available. - The company successfully completed the cash-funded acquisition of BroadPath without borrowing. - No immediate plans for new debt or equity fundraising were mentioned in the discussion.

- The company is actively looking at all deals that come to the table. - They will pursue good opportunities available at reasonable valuations. - The deal pipeline remains strong with ongoing active conversations. - They are in the final stages of discussions with at least three additional clients. - There is no perceived slowdown in deal closures or pipeline despite macroeconomic uncertainties. - Profitability pressures on clients have increased their propensity to engage with Sagility, potentially increasing opportunity volume. - The company continues to add new clients; eight new clients were added in the reported year, including two or three in the last quarter. - BroadPath acquisition has further diversified the client base and growth opportunities.